Stocktoria

HEALTHY EXTRACTS INC. HYEX

OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-10-13

HEALTHY EXTRACTS INC. financials (annual, from 10-K)

Revenue
2023202420242024202420252025202520252026
Net income
2023202420242024202420252025202520252026
Free cash flow
2023202420242024202420252025202520252026

Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2025FY2025FY2025FY2024FY2024FY2024FY2024FY2023
Revenue$4.5M$3.1M$2.5M
Gross profit$2.4M$1.9M$1.6M
Income tax$0$0$0
Net income$20.3M-$881,119$20.0M$19.6M$19.6M-$840,671$18.8M$19.1M$19.3M-$2.5M
Operating cash flow$165,520$281,968-$415,749
Free cash flow-$415,749
Inventory$520,752$843,357$966,522$1.1M$1.1M$1.4M$1.4M$1.3M$1.6M$1.6M
Total assets$27.3M$27.8M$26.2M$2.5M$2.4M$2.4M$2.5M$2.5M$2.6M$2.6M
Total liabilities$3.3M$3.8M$2.1M$2.0M$2.0M
Shareholders' equity$24.0M$24.0M$24.1M$477,958$60,508$151,646$802,961$400,000$151,646$954,590

Growth · year-over-year · Revenue CAGR 34.7%

MetricFY2026FY2025FY2025FY2025FY2025FY2024FY2024FY2024FY2024FY2023
Net income growth-104.4%+2.0%-0.3%-104.5%-1.9%-0.6%-113.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001630176 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.